NO975554L - Oral toleranse i hudsykdommer tilstede med T-celle mediert inflammasjon - Google Patents

Oral toleranse i hudsykdommer tilstede med T-celle mediert inflammasjon

Info

Publication number
NO975554L
NO975554L NO975554A NO975554A NO975554L NO 975554 L NO975554 L NO 975554L NO 975554 A NO975554 A NO 975554A NO 975554 A NO975554 A NO 975554A NO 975554 L NO975554 L NO 975554L
Authority
NO
Norway
Prior art keywords
cell mediated
skin diseases
oral tolerance
mediated inflammation
diseases present
Prior art date
Application number
NO975554A
Other languages
English (en)
Other versions
NO975554D0 (no
Inventor
Howard L Weiner
Thomas S Kupper
Youhai Chen
Original Assignee
Autoimmune Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Autoimmune Inc filed Critical Autoimmune Inc
Publication of NO975554L publication Critical patent/NO975554L/no
Publication of NO975554D0 publication Critical patent/NO975554D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Det er beskrevet fremgangsmåter og sammensetninger for behandling av hud- sykdommer tilstede med T-cellemediert eller T-celleavhengig inflammasjon. Det er også beskrevet fremgangsmåter og sammensetninger for behandling av slike sykdommer gjennom oral administrering av et hudassosiert tilstedeværende antigen.
NO975554A 1995-06-07 1997-12-02 Oral toleranse i hudsykdommer tilstede med T-celle mediert inflammasjon NO975554D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48619095A 1995-06-07 1995-06-07
PCT/US1996/010384 WO1996040232A1 (en) 1995-06-07 1996-06-05 Oral tolerance in skin diseases presenting with t-cell mediated inflammation

Publications (2)

Publication Number Publication Date
NO975554L true NO975554L (no) 1997-12-02
NO975554D0 NO975554D0 (no) 1997-12-02

Family

ID=23930947

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975554A NO975554D0 (no) 1995-06-07 1997-12-02 Oral toleranse i hudsykdommer tilstede med T-celle mediert inflammasjon

Country Status (10)

Country Link
EP (1) EP0871478A1 (no)
JP (1) JPH11507383A (no)
KR (1) KR19990022556A (no)
AU (1) AU6333796A (no)
BR (1) BR9609014A (no)
CA (1) CA2219457A1 (no)
HU (1) HUP9901077A3 (no)
IL (1) IL122502A0 (no)
NO (1) NO975554D0 (no)
WO (1) WO1996040232A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999064066A1 (fr) * 1998-06-09 1999-12-16 Shionogi & Co., Ltd. Agents induisant une tolerance immunitaire et contenant de la keratine dure ou une substance ressemblant a la keratine
IL126447A (en) * 1998-10-04 2004-09-27 Vascular Biogenics Ltd An immune preparation that confers tolerance in oral administration and its use in the prevention and / or treatment of atherosclerosis
KR102027451B1 (ko) 2012-11-02 2019-10-02 (주)아모레퍼시픽 마이크로 rna 및 이를 사용하는 스크리닝 방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399347A (en) * 1987-06-24 1995-03-21 Autoimmune, Inc. Method of treating rheumatoid arthritis with type II collagen

Also Published As

Publication number Publication date
HUP9901077A2 (hu) 1999-07-28
WO1996040232A1 (en) 1996-12-19
EP0871478A1 (en) 1998-10-21
BR9609014A (pt) 1999-12-14
KR19990022556A (ko) 1999-03-25
HUP9901077A3 (en) 1999-11-29
IL122502A0 (en) 1998-06-15
JPH11507383A (ja) 1999-06-29
CA2219457A1 (en) 1996-12-19
NO975554D0 (no) 1997-12-02
AU6333796A (en) 1996-12-30

Similar Documents

Publication Publication Date Title
DK1035834T3 (da) Osmotisk doseringsform omfattende en første og anden coating
PT946151E (pt) Forma de dosagem de dose crescente
HUP0102033A2 (hu) PEG IFN-alfa és ribavirin felhasználása krónikus hepatitis C kezelésére
NO995718L (no) Urte-ekstraktsammensetning og metode med innum-"boosting"- evne
ATE193444T1 (de) Gefriergetrocknete ondansetron zubereitungen
EE04606B1 (et) H+, K+-ATPaasi inhibiitori kasutamine ravimi valmistamiseks peroraalseks manustamiseks
ZA967880B (en) Compositions and methods for inhibition of the patho-physiologic actions in mammals in tumor necrosis facto-alpha
NO990934L (no) Anvendelse av arakidonsyre og/eller dokosaheksansyre for fremstilling av et medikament for behandling av dyspraksi
DE69424777D1 (de) 3,4-diarylchromane zur behandlung von dermatitis
SE9603725D0 (sv) New teatment
DK0817646T3 (da) Fremgangsmåder til behandling af inflammation og præparater derfor
BR9809678A (pt) Derivados de triptolìdeo úteis no tratamento de doenças autoimunes
NO931413L (no) Fremgangsmaater og preparater for behandling av celleproliferasjonssykdommer
NO975554L (no) Oral toleranse i hudsykdommer tilstede med T-celle mediert inflammasjon
WO1996020950A3 (en) Compositions and methods for treating rheumatoid arthritis
NO955084L (no) Estrensteroider som nevrokjemiske initiatorer for forandring i menneskets hypotalamiske funksjon og beslektede farmasöytiske blandinger og metoder
DE69928523D1 (de) Verotoxin b untereinheit zur immunisierunug
PT862454E (pt) Novas utilizacoes de ctla-8 de mamifero e reagentes relacionados
DK0859630T3 (da) Kombination af termozolomid og alfa-IFN til behandling af fremskreden cancer
NO993921D0 (no) Medikament mot infertilitet og for ökt fertilitet
NO985695L (no) Formulering og fremgangsmÕte for Õ behandle kongestiv hjerteinfarkt
ES2161809T3 (es) Uso de factor proliferativo osteoblastico.
AU784159C (en) Method and compositions for administering taxanes orally to human patients
RU94036344A (ru) Способ лечения спида
UA23985A (uk) Спосіб лікуваhhя запальhих захворюваhь вhутрішhіх геhіталій у дівчат та підлітків

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application